Global Human Milk Oligosaccharides (HMO) Market Size By Type, By Application, By Geographic Scope And Forecast

Human Milk Oligosaccharides (HMO) Market Size And Forecast

Human Milk Oligosaccharides (HMO) Market size was valued at USD 203.3 Million in 2023 and is projected to reach USD 615.2 Million by 2030, growing at a CAGR of 21.13% during the forecast period 2024-2030.

Global Human Milk Oligosaccharides (HMO) Market Drivers

The market drivers for the Human Milk Oligosaccharides (HMO) Market can be influenced by various factors. These may include

• Growing Knowledge of Health Benefits The demand for HMO-based products in baby formula and nutritional supplements is driven by growing knowledge of the health benefits linked to human milk oligosaccharides, such as boosting gut health, lowering the risk of infections, and supporting the development of the infant immune system.
• Growing Need for Infant Nutrition The demand for baby food and formula is rising, particularly in emerging economies, as a result of changing lifestyles, urbanization, and rising birth rates. As the importance of HMOs in newborn nutrition becomes more widely acknowledged, formula manufacturers are include them in their products to replicate the makeup of human breast milk.
• Advancements in Biotechnology Technological developments in biotechnology and glycoscience have made it possible to produce HMOs commercially via enzymatic synthesis or microbial fermentation. These developments have increased the availability of HMOs for usage in a range of applications, reduced production costs, and enhanced scalability.
• Innovation in Functional Food and Beverage HMOs are being investigated for their potential uses in food and beverage applications that go beyond baby nutrition. The prebiotic properties of HMOs, along with their potential health advantages and the desire of consumers for natural, bioactive ingredients, have led to their integration into dairy products, drinks, and functional meals.
• Trends in Health and Wellbeing HMO demand is driven by rising consumer interest in health and wellness as well as a preference for natural and clean-label components in nutraceuticals, nutritional supplements, and functional foods. HMOs are thought to be naturally occurring bioactive substances that improve gut health and general wellbeing.
• Research and Clinical Evidence A growing body of scientific literature and clinical research attests to the health benefits of HMOs, including their capacity to influence immunological responses, inhibit pathogen adhesion, and shape the gut microbiome of infants. Positive research study results support consumer acceptance and confidence in HMO-based solutions.
• Regulatory Support and Approvals The safety and effectiveness of HMOs for use in baby formula and food applications are validated by regulatory approvals and endorsements from health authorities and regulatory bodies, such as the European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration (FDA). Support from regulations makes it easier to enter markets and commercialize products.
• Investment and Collaboration The HMO market is driven by increased investment from food and pharmaceutical firms, as well as partnerships between academic institutions, research centers, and industry participants. Collaborations and partnerships facilitate the transfer of technology, the exchange of expertise, and the creation of new HMO-based products.

Global Human Milk Oligosaccharides (HMO) Market Restraints

Several factors can act as restraints or challenges for the Human Milk Oligosaccharides (HMO) Market. These may include

• High Production Costs It can be costly and complex to produce HMOs, particularly those that are generated from human breast milk. The price and accessibility of HMO-based goods may be restricted by high production costs, especially in emerging economies where cost sensitivity is paramount.
• Limited Supply Chain Capacity Scalability, production capacity, and infrastructure constraints may provide problems for the supply chain of HMOs, especially those made using biotechnological techniques. The availability of HMOs for use in a variety of applications may be restricted by limited supply chain capacity, impeding market expansion.
• Regulatory Difficulties Different regions and nations have different regulatory criteria and approval procedures for novel components like HMOs. Market introduction and commercialization of HMO-based products may be delayed by the time-consuming and expensive processes required to get regulatory clearances.
• Consumer Acceptance and Awareness Although the health benefits of HMOs are becoming more well-known, there may be differences in the way that consumers embrace and comprehend these elements. Adoption of HMO-based goods may be impeded by consumers who lack knowledge about HMOs or who have doubts about their effectiveness.
• Competition from Alternatives Nutritional supplements, functional additives, and alternative prebiotics used in baby formula, food, and drink products compete with HMOs. The market for HMOs may decline if manufacturers decide to switch to cheaper substitutes with comparable functions.
• Ethical and Social Considerations Cultural, religious, or ethical attitudes may give rise to concerns over the ethical sourcing of HMOs, especially those obtained from human breast milk. The use of HMOs derived from human breast milk may give rise to ethical concerns from certain consumers and advocacy groups.
• Intellectual Property Rights Patents, proprietary technology, and intellectual property rights related to HMO production techniques may make it difficult for new players to enter the market. Patent disputes, intellectual property lawsuits, and licensing agreements may have an effect on innovation and market competitiveness.
• Health and Safety Concerns Although HMOs are usually thought to be safe to eat, there may be worries about possible allergies, side effects, or negative reactions. These worries are especially relevant in sensitive groups, such as newborns with underlying medical issues. For a product to be accepted by the market, safety issues must be addressed and product quality and purity must be guaranteed.

Global Human Milk Oligosaccharides (HMO) Market Segmentation Analysis

The Global Human Milk Oligosaccharides (HMO) Market is Segmented on the basis of Type, Application, And Geography.

Human Milk Oligosaccharides (HMO) Market, By Type

• 2’FL (2′-Fucosyllactose) A common HMO that boosts the immune system.
• 3’FL (3′-Fucosyllactose) An additional popular HMO that has been shown to affect gut microbiota.
• 3’SL (3′-Sialyllactose) An HMO that may help with brain growth.
• 6’SL (6′-Sialyllactose) An additional HMO that may be related to mental processes.
• LNT & LNnT (Lewis structures) Lewis structures, or LNT & LNnT, are a class of HMOs with a range of health advantages.

Human Milk Oligosaccharides (HMO) Market, By Application

• Infant formulaThe market leader, using HMOs to replicate the qualities of breast milk.
• Functional Food & Beverages An expanding market that uses HMOs to support immune system and digestive health.
• Food Supplements For specific health effects, HMOs are being utilized more and more in stand-alone supplements.
• Ingredients for Health (Human & Animal) HMOs are being investigated for uses other than human health, such as helping animals’ digestive systems.
• Others This could include recently developed products like personal care items or sports nutrition.

Human Milk Oligosaccharides (HMO) Market, By Geography

• North America Market conditions and demand in the United States, Canada, and Mexico.
• Europe Analysis of the Human Milk Oligosaccharides (HMO) Market in European countries.
• Asia-Pacific Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa Examining market dynamics in the Middle East and African regions.
• Latin America Covering market trends and developments in countries across Latin America.

Key Players

The major players in the Human Milk Oligosaccharides (HMO) Market are

• Royal DSM
• Chr. Hansen Holding A/S
• BASF SE
• DuPont de Nemours, Inc.
• Nestlé
• Abbott Laboratories
• Inbiose NV
• Elicityl SA
• Jennewein Biotechnologie
• ZuChem

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.